Vasculitis UK Funds COVID-19 Vaccine Study

Vasculitis UK Funds COVID-19 Vaccine Study

291784

Vasculitis UK Funds COVID-19 Vaccine Study

Vasculitis UK has granted £53,364 (about $73,500) to support a research project investigating how people with ANCA-associated vasculitis (AAV) and other vasculitis respond to COVID-19 vaccines.  Led by Lucy Fairclough, PhD, an associate professor at Nottingham University, in the U.K., the project seeks to determine if these patients mount an effective response to vaccination and whether that response is sustained. “The results from this study will be used to inform discussions with the makers of health…

You must be logged in to read/download the full post.